OLIG2 is a pan-glioma marker also expressed in a rare cell population within human MBs.4 Previous studies demonstrated that Olig2 represses p53-mediated transcriptional activities, by inhibiting acetylation of p53, and directly represses transcription of p2131,32. This evidence concerns the gene TP53 and central nervous system cancer.